Pliant Therapeutics Inc. (PLRX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pliant Therapeutics Inc.

    NASDAQ: PLRX · Real-Time Price · USD
    1.52
    0.08 (5.56%)
    At close: Sep 26, 2025, 3:59 PM
    1.47
    -3.29%
    After-hours: Sep 26, 2025, 07:53 PM EDT

    Pliant Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -3.79 -6.59 -6.59 -4.98
    PEG Ratio
    		 -0.14 1.02 -0.78 -0.04
    PS Ratio
    		 n/a 673.04 83.86 63.91
    PB Ratio
    		 2.62 2.25 2.59 2.43
    P/FCF Ratio
    		 -5 -9.07 -8.43 -6.25
    P/OCF Ratio
    		 -5.13 -9.14 -8.58 -6.41
    OCF/S Ratio
    		 n/a -73.65 -9.77 -9.96
    Debt / Equity Ratio
    		 0.20 0.02 0.05 0.04
    Quick Ratio
    		 10.91 17.72 14.23 12.44
    Current Ratio
    		 10.91 17.72 14.23 12.44
    Asset Turnover
    		 n/a 0.00 0.03 0.03
    Interest Coverage
    		 -75.52 -145.34 -160.81 n/a
    Return on Equity
    		 -0.69 -0.34 -0.39 -0.49
    Return on Assets
    		 -0.53 -0.32 -0.35 -0.44
    Return on Invested Capital
    		 -0.63 -0.38 -0.38 -0.47
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a 1.00 1.00 1.00
    Net Profit Margin
    		 n/a -102.11 -12.73 -12.85
    Pretax Profit Margin
    		 n/a -102.11 -12.73 -12.85
    Operating Profit Margin
    		 n/a -116.55 -13.13 -12.88
    FCF Margin
    		 n/a -74.23 -9.95 -10.22
    EBITDA Margin
    		 n/a -100.14 -12.27 -12.64

    Add to Watchlist